Michael Secora Recursion Pharmaceuticals, Inc. (RXRX) insider trading activity

Michael Secora is Chief Financial Officer of RECURSION PHARMACEUTICALS, INC.. Currently has a direct ownership of 1.49 Million shares of RXRX, which is worth approximately $8.55 Million. The most recent transaction as insider was on Nov 15, 2023, when has been sold 7,172 shares (Class A Common Stock) at a price of $7.18 per share, resulting in proceeds of $51,494. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 1.49M

9.92% 3M change

59.79% 12M change

Total Value Held $8.55 Million

Michael Secora Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Nov 15 2023	SELL Payment of exercise price or tax liability	$51,494 $7.18 p/Share	7,172 Reduced 0.76%	931,014 Class A Common Stock
Nov 15 2023	SELL Open market or private sale	$186,000 $7.44 p/Share	25,000 Reduced 2.6%	938,186 Class A Common Stock
Nov 15 2023	BUY Exercise of conversion of derivative security	$83,250 $2.22 p/Share	37,500 Added 3.75%	963,186 Class A Common Stock
Nov 14 2023	SELL Open market or private sale	$158,000 $6.32 p/Share	25,000 Reduced 2.63%	925,686 Class A Common Stock
Nov 14 2023	BUY Exercise of conversion of derivative security	$83,250 $2.22 p/Share	37,500 Added 3.79%	950,686 Class A Common Stock
Oct 11 2023	SELL Open market or private sale	$171,250 $6.85 p/Share	25,000 Reduced 2.66%	913,186 Class A Common Stock
Oct 11 2023	BUY Exercise of conversion of derivative security	$83,250 $2.22 p/Share	37,500 Added 3.84%	938,186 Class A Common Stock
Oct 10 2023	SELL Open market or private sale	$176,750 $7.07 p/Share	25,000 Reduced 2.7%	900,686 Class A Common Stock
Oct 10 2023	BUY Exercise of conversion of derivative security	$83,250 $2.22 p/Share	37,500 Added 3.89%	925,686 Class A Common Stock
Sep 13 2023	SELL Open market or private sale	$217,250 $8.69 p/Share	25,000 Reduced 2.74%	888,186 Class A Common Stock
Sep 13 2023	BUY Exercise of conversion of derivative security	$83,250 $2.22 p/Share	37,500 Added 3.94%	913,186 Class A Common Stock
Sep 12 2023	SELL Open market or private sale	$210,750 $8.43 p/Share	25,000 Reduced 2.78%	875,686 Class A Common Stock
Sep 12 2023	BUY Exercise of conversion of derivative security	$83,250 $2.22 p/Share	37,500 Added 4.0%	900,686 Class A Common Stock
Aug 16 2023	SELL Open market or private sale	$222,500 $8.9 p/Share	25,000 Reduced 2.81%	863,186 Class A Common Stock
Aug 16 2023	BUY Exercise of conversion of derivative security	$83,250 $2.22 p/Share	37,500 Added 4.05%	888,186 Class A Common Stock
Aug 15 2023	SELL Open market or private sale	$231,750 $9.27 p/Share	25,000 Reduced 2.85%	850,686 Class A Common Stock
Aug 15 2023	SELL Payment of exercise price or tax liability	$43,441 $9.19 p/Share	4,727 Reduced 0.56%	838,186 Class A Common Stock
Aug 15 2023	BUY Exercise of conversion of derivative security	$83,250 $2.22 p/Share	37,500 Added 4.11%	875,686 Class A Common Stock
Jul 19 2023	SELL Open market or private sale	$381,000 $15.24 p/Share	25,000 Reduced 2.88%	842,913 Class A Common Stock
Jul 19 2023	BUY Exercise of conversion of derivative security	$83,250 $2.22 p/Share	37,500 Added 4.14%	867,913 Class A Common Stock
Jul 18 2023	SELL Open market or private sale	$346,000 $13.84 p/Share	25,000 Reduced 2.92%	830,413 Class A Common Stock
Jul 18 2023	BUY Exercise of conversion of derivative security	$83,250 $2.22 p/Share	37,500 Added 4.2%	855,413 Class A Common Stock
Jun 14 2023	SELL Open market or private sale	$251,750 $10.07 p/Share	25,000 Reduced 2.97%	817,913 Class A Common Stock
Jun 14 2023	BUY Exercise of conversion of derivative security	$83,250 $2.22 p/Share	37,500 Added 4.26%	842,913 Class A Common Stock
Jun 13 2023	SELL Open market or private sale	$248,250 $9.93 p/Share	25,000 Reduced 3.01%	805,413 Class A Common Stock

Michael Secora

Chief Financial Officer

Salt Lake City, UT

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells RXRX shares.

Notify only if

Value

Insider Trading

Get notified when an Recursion Pharmaceuticals, Inc. insider buys or sells RXRX shares.

Notify only if

Operation

Value

Type

News

Receive news related to RECURSION PHARMACEUTICALS, INC.

Track Activities on RXRX

Account